GT Biopharma, Inc. (GTBP)
0.7458
+0.02
(+2.16%)
USD |
NASDAQ |
Jan 16, 16:00
0.73
-0.02
(-2.12%)
Pre-Market: 08:45
GT Biopharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | -- |
| Lyell Immunopharma, Inc. | -259.0K% |
| Geron Corp. | -39.02% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Xencor, Inc. | -28.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -626.2% |
| Return on Assets | -181.3% |
| Return on Invested Capital | -626.2% |